These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 7308159)

  • 1. 1-34 Human parathyroid hormone radioimmunoassay: properties of antiserum against synthetic 1-34 human parathyroid hormone and its clinical application.
    Shiraki M; Kawada N; Akiguchi I; Yamauchi H; Kojima A; Orimo H
    Endocrinol Jpn; 1981 Apr; 28(2):239-44. PubMed ID: 7308159
    [No Abstract]   [Full Text] [Related]  

  • 2. Properties of antisera against synthetic 1--34 human parathyroid hormone.
    Visser TJ; Buurman CJ; Hackeng WH; Birkenhäger JC
    J Endocrinol; 1975 Oct; 67(1):141-2. PubMed ID: 1194825
    [No Abstract]   [Full Text] [Related]  

  • 3. Homologous radioimmunoassay for human carboxyl-terminal parathyroid hormone and its clinical evaluation.
    Tomita A; Yoneda M; Takano T; Uchikawa T; Takatsuki K; Katsuragi S; Noda T; Watanabe S
    Endocrinol Jpn; 1983 Oct; 30(5):585-92. PubMed ID: 6671460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isolation of circulating immunoreactive human parathyroid hormone: comparison with a 1-34 N-terminal synthetic fragment.
    Desplan C; Jullienne A; Moukhtar MS; Raulais D; Rivaille P; Milhaud G
    Proc Soc Exp Biol Med; 1978 Feb; 157(2):241-4. PubMed ID: 622389
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunological properties of synthetic human parathyroid hormone: effect of deamidation at position 76.
    Gleed JH; Hendy GN; Kimura T; Sakakibara S; O'Riordan JL
    Bone Miner; 1987 Aug; 2(5):375-82. PubMed ID: 2464379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Production and characterization of antisera to synthetic 1-34 human parathyroid hormone fragments: possible implications for the correctness of proposed structures.
    Visser TJ; Buurman CJ; Birkenhäger JC
    Acta Endocrinol (Copenh); 1979 Jan; 90(1):90-102. PubMed ID: 760361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Experience with a radioimmunoassay of parathyroid hormone in human sera.
    Reiss E; Canterbury JM; Egdahl RH
    Trans Assoc Am Physicians; 1968; 81():104-15. PubMed ID: 5721395
    [No Abstract]   [Full Text] [Related]  

  • 8. Human parathyroid hormone: immunological properties of the amino terminus and of synthetic fragments.
    Hendy GN; Barling PM; O'Riordan JL
    Clin Sci Mol Med; 1974 Dec; 47(6):567-76. PubMed ID: 4476267
    [No Abstract]   [Full Text] [Related]  

  • 9. Cleavage-associated enhancement of an antigenic site in the biologically active NH2-terminal region of parathyroid hormone.
    Habener JF; Potts JT
    Endocrinology; 1979 Jul; 105(1):115-9. PubMed ID: 87321
    [No Abstract]   [Full Text] [Related]  

  • 10. Immunological studies on parathyroid hormone: characterization of antisera against synthetic 1-34 human parathyroid hormone and evidence that position 30 in human parathyroid hormone is aspartic acid.
    Visser TJ; Buurman CJ; Birkenhäger JC
    J Endocrinol; 1977 Sep; 74(3):461-6. PubMed ID: 925571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of an homologous radioimmunoassay for the synthetic amino terminal (1-34) fragment of human parathyroid hormone using egg yolk-obtained antibodies.
    Vieira JG; Oliveira MA; Maciel RM; Mesquita CH; Russo EM
    J Immunoassay; 1986; 7(1-2):57-72. PubMed ID: 3734109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunological properties of synthetic human parathyroid hormone 53--84 fragment.
    Hendy GN; Manning RM; Rosenblatt M; Tregear GW; Keutmann HT; O'Riordan JL
    J Endocrinol; 1979 Jan; 80(1):153-5. PubMed ID: 429948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radioimmunoassay of parathyroid hormone in human plasma and tissue using commercially available antiserum and modified iodination.
    Tanaka M; Abe K; Adachi I; Miyakawa S; Kumaoka S
    Endocrinol Jpn; 1974 Apr; 21(2):173-8. PubMed ID: 4408342
    [No Abstract]   [Full Text] [Related]  

  • 14. A "carboxyl terminal" clinical radioimmunoassay for parathyroid hormone with apparent recognition preference for the intact hormone.
    Hanley DA; Wellings PG
    J Immunoassay; 1985; 6(3):245-59. PubMed ID: 2413077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunological evidences for the presence of small late carboxylterminal fragment(s) of human parathyroid hormone (PTH) in circulation in man.
    D'Amour P; Labelle F; Wolde-Giorghis R; Hamel L
    J Immunoassay; 1989; 10(2-3):191-205. PubMed ID: 2745718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PTH activity as determined by canine renal cortical adenylate cyclase assay in chronic renal failure.
    Morita M
    Nihon Jinzo Gakkai Shi; 1987 May; 29(5):535-9. PubMed ID: 3656711
    [No Abstract]   [Full Text] [Related]  

  • 17. Evaluation of a mid-molecule parathyroid hormone radioimmunoassay.
    Yatscoff RW; Desjardins PR; Krahn J
    Clin Chem; 1987 Jun; 33(6):1074. PubMed ID: 3594791
    [No Abstract]   [Full Text] [Related]  

  • 18. Influence of immunoheterogeneity of circulating parathyroid hormone on results of radioimmunoassays of serum in man.
    Arnaud CD; Goldsmith RS; Bordier PJ; Sizemore GW
    Am J Med; 1974 Jun; 56(6):785-93. PubMed ID: 4133939
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical significance of amino-terminal radioimmunoassay of parathyroid hormone concentration].
    Meng XW; Liu SQ; Zhou XY
    Zhonghua Nei Ke Za Zhi; 1986 Feb; 25(2):65-8, 125. PubMed ID: 3792123
    [No Abstract]   [Full Text] [Related]  

  • 20. Pharmacokinetics of synthetic human parathyroid hormone 1-34 in man measured by cytochemical bioassay and radioimmunoassay.
    Kent GN; Loveridge N; Reeve J; Zanelli JM
    Clin Sci (Lond); 1985 Feb; 68(2):171-7. PubMed ID: 3967464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.